Tekla Healthcare Investors (HQH) 34.20 $HQH
Uptrend Call Working As H&Q Healthcare Investors Stock Rises 18.4% (HQH)
Comtex SmarTrend(R) - Fri Feb 13, 11:08AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 4 months, H&Q Healthcare Investors has returned 18.39% as of today's recent price of $34.21.
HQH: 34.20 (+0.06)
Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 52.78 (+0.30), HQL: 27.40 (+0.16), FBT: 110.21 (+1.02), PJP: 73.81 (+0.69), XBI: 203.40 (+1.36), XPH: 118.58 (+0.98), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06)
H&Q Healthcare Investors Up 16.2% Since SmarTrend Uptrend Call (HQH)
Comtex SmarTrend(R) - Fri Feb 06, 9:52AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 4 months, H&Q Healthcare Investors has returned 16.23% as of today's recent price of $33.59.
HQH: 34.20 (+0.06)
Tekla Healthcare Opportunities Fund Pays Distribution
Business Wire - Fri Jan 30, 3:44PM CST
On January 30, 2015, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $132,486,213, of which $103,427,424 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
20.4% Return Seen to Date on SmarTrend H&Q Healthcare Investors Call (HQH)
Comtex SmarTrend(R) - Fri Jan 30, 9:17AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 3 months, H&Q Healthcare Investors has returned 20.42% as of today's recent price of $34.80.
HQH: 34.20 (+0.06)
Getting The Defense On The Field
Left Banker - at Seeking Alpha - Fri Jan 16, 8:47AM CST
PDI: 29.51 (unch), SPLV: 38.18 (-0.27), ETG: 16.61 (+0.10), VFC: 75.26 (+4.26), VIG: 82.39 (+0.48), WFC: 55.33 (+0.47), JTD: 16.17 (+0.02), TLT: 128.19 (-1.33), T: 34.66 (+0.05), JRI: 19.24 (+0.12), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), UTG: 31.01 (-0.73), OXLC: 15.22 (-0.12), ETY: 11.52 (+0.05), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), USMV: 41.48 (+0.03), AFL: 62.13 (+0.33), RQI: 12.36 (-0.10), SDY: 79.16 (+0.32)
H&Q Healthcare Investors Shares Up 14.8% Since SmarTrend's Buy Recommendation (HQH)
Comtex SmarTrend(R) - Wed Jan 14, 11:23AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 3 months, H&Q Healthcare Investors has returned 14.79% as of today's recent price of $33.17.
HQH: 34.20 (+0.06)
A Diversified, High-Income, Lower-Risk CEF Portfolio For 2015
John Dowdee - at Seeking Alpha - Thu Jan 01, 6:59AM CST
PFN: 10.19 (+0.01), INB: 12.10 (unch), JCE: 17.57 (-0.01), RNP: 19.44 (-0.06), PDT: 14.20 (+0.02), SCD: 16.98 (-0.05), PKO: 24.97 (+0.05), NHF: 11.69 (+0.08), PCM: 10.71 (-0.01), HQH: 34.20 (+0.06), ETW: 11.79 (-0.06), KED: 34.92 (+1.14)
Tekla Healthcare Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Healthcare Investors paid a quarterly stock distribution of $0.59 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $500,963,482, of which $504,847,623 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
Tekla Life Sciences Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Life Sciences Investors paid a quarterly stock distribution of $0.47 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $209,374,949, of which $208,409,663 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
SA Editors - Seeking Alpha - Tue Dec 30, 6:05AM CST
Today we present the fifth piece in Seeking Alpha's Positioning for 2015 series. This year we have once again asked experts on a range of different asset classes and investing strategies to offer their vision for the coming year and beyond....
BIIB: 391.66 (-0.45), SPY: 209.78 (+0.86), PTLA: 34.96 (+3.13), PCYC: 163.28 (+0.23), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), MRK: 58.81 (-0.07), EW: 134.23 (+1.89), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06), REGN: 402.40 (+0.66), CELG: 115.88 (+0.16)
H&Q Healthcare Investors Has Returned 15.3% Since SmarTrend Recommendation (HQH)
Comtex SmarTrend(R) - Wed Dec 10, 10:01AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 2 months, H&Q Healthcare Investors has returned 15.35% as of today's recent price of $33.33.
HQH: 34.20 (+0.06)
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Business Wire - Mon Dec 08, 9:00AM CST
CardioKinetix, Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed a $50 million financing led by Edwards Lifesciences Corporation, with participation from existing investors U.S. Venture Partners, Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL), SV Life Sciences, Panorama Capital, New Leaf Venture Partners, and Lexington Private Equity.
HQL: 27.40 (+0.16), EW: 134.23 (+1.89), HQH: 34.20 (+0.06)
Update: Double-Digit Distribution Portfolio
Left Banker - at Seeking Alpha - Tue Dec 02, 2:42AM CST
PDI: 29.51 (unch), NFJ: 16.41 (-0.10), PCI: 20.56 (+0.02), IGA: 11.64 (+0.02), DVHL: 24.31 (+0.24), SDRL: 12.32 (-0.70), MORL: 19.93 (+0.09), GGN: 7.59 (+0.12), BQR: 7.57 (+0.01), EOS: 14.19 (+0.11), JRI: 19.24 (+0.12), BIT: 17.66 (-0.01), BOE: 13.57 (+0.08), EDI: 14.88 (+0.18), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), OXLC: 15.22 (-0.12), EDF: 15.46 (+0.03), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), TYG: 44.58 (+0.21)
Tekla Healthcare Opportunities Introduces Fact Card
Business Wire - Tue Nov 18, 10:44AM CST
Tekla Healthcare Opportunities Fund (NYSE: THQ) is pleased to introduce its first fact card. The fact card, which summarizes Fund information which may include quarterly data regarding the Fund including performance, portfolio holdings and sector information, will be available at www.teklacap.com or by request from the Fund's marketing and support services agent, Destra Capital Investments at (877)855-3434. The Fund intends to publish and distribute fact cards with quarterly data within approximately 15 days after each quarter's end. Please visit the Fund's website or call Destra Capital Investments to obtain the Fund's fact cards as published.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
Uptrend Call Working As H&Q Healthcare Investors Stock Rises 18.4% (HQH)
Comtex SmarTrend(R) - Fri Feb 13, 11:08AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 4 months, H&Q Healthcare Investors has returned 18.39% as of today's recent price of $34.21.
HQH: 34.20 (+0.06)
Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST
PBE: 52.78 (+0.30), HQL: 27.40 (+0.16), FBT: 110.21 (+1.02), PJP: 73.81 (+0.69), XBI: 203.40 (+1.36), XPH: 118.58 (+0.98), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06)
H&Q Healthcare Investors Up 16.2% Since SmarTrend Uptrend Call (HQH)
Comtex SmarTrend(R) - Fri Feb 06, 9:52AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 4 months, H&Q Healthcare Investors has returned 16.23% as of today's recent price of $33.59.
HQH: 34.20 (+0.06)
Tekla Healthcare Opportunities Fund Pays Distribution
Business Wire - Fri Jan 30, 3:44PM CST
On January 30, 2015, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $132,486,213, of which $103,427,424 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
20.4% Return Seen to Date on SmarTrend H&Q Healthcare Investors Call (HQH)
Comtex SmarTrend(R) - Fri Jan 30, 9:17AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 3 months, H&Q Healthcare Investors has returned 20.42% as of today's recent price of $34.80.
HQH: 34.20 (+0.06)
Getting The Defense On The Field
Left Banker - at Seeking Alpha - Fri Jan 16, 8:47AM CST
PDI: 29.51 (unch), SPLV: 38.18 (-0.27), ETG: 16.61 (+0.10), VFC: 75.26 (+4.26), VIG: 82.39 (+0.48), WFC: 55.33 (+0.47), JTD: 16.17 (+0.02), TLT: 128.19 (-1.33), T: 34.66 (+0.05), JRI: 19.24 (+0.12), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), UTG: 31.01 (-0.73), OXLC: 15.22 (-0.12), ETY: 11.52 (+0.05), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), USMV: 41.48 (+0.03), AFL: 62.13 (+0.33), RQI: 12.36 (-0.10), SDY: 79.16 (+0.32)
H&Q Healthcare Investors Shares Up 14.8% Since SmarTrend's Buy Recommendation (HQH)
Comtex SmarTrend(R) - Wed Jan 14, 11:23AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 3 months, H&Q Healthcare Investors has returned 14.79% as of today's recent price of $33.17.
HQH: 34.20 (+0.06)
A Diversified, High-Income, Lower-Risk CEF Portfolio For 2015
John Dowdee - at Seeking Alpha - Thu Jan 01, 6:59AM CST
PFN: 10.19 (+0.01), INB: 12.10 (unch), JCE: 17.57 (-0.01), RNP: 19.44 (-0.06), PDT: 14.20 (+0.02), SCD: 16.98 (-0.05), PKO: 24.97 (+0.05), NHF: 11.69 (+0.08), PCM: 10.71 (-0.01), HQH: 34.20 (+0.06), ETW: 11.79 (-0.06), KED: 34.92 (+1.14)
Tekla Healthcare Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Healthcare Investors paid a quarterly stock distribution of $0.59 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $500,963,482, of which $504,847,623 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
Tekla Life Sciences Investors Pays Distribution
Business Wire - Wed Dec 31, 11:25AM CST
On December 31, 2014, Tekla Life Sciences Investors paid a quarterly stock distribution of $0.47 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $209,374,949, of which $208,409,663 represents net unrealized appreciation of portfolio securities.
HQL: 27.40 (+0.16), HQH: 34.20 (+0.06)
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
SA Editors - Seeking Alpha - Tue Dec 30, 6:05AM CST
Today we present the fifth piece in Seeking Alpha's Positioning for 2015 series. This year we have once again asked experts on a range of different asset classes and investing strategies to offer their vision for the coming year and beyond....
BIIB: 391.66 (-0.45), SPY: 209.78 (+0.86), PTLA: 34.96 (+3.13), PCYC: 163.28 (+0.23), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), MRK: 58.81 (-0.07), EW: 134.23 (+1.89), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06), REGN: 402.40 (+0.66), CELG: 115.88 (+0.16)
H&Q Healthcare Investors Has Returned 15.3% Since SmarTrend Recommendation (HQH)
Comtex SmarTrend(R) - Wed Dec 10, 10:01AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 2 months, H&Q Healthcare Investors has returned 15.35% as of today's recent price of $33.33.
HQH: 34.20 (+0.06)
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Business Wire - Mon Dec 08, 9:00AM CST
CardioKinetix, Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed a $50 million financing led by Edwards Lifesciences Corporation, with participation from existing investors U.S. Venture Partners, Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL), SV Life Sciences, Panorama Capital, New Leaf Venture Partners, and Lexington Private Equity.
HQL: 27.40 (+0.16), EW: 134.23 (+1.89), HQH: 34.20 (+0.06)
Update: Double-Digit Distribution Portfolio
Left Banker - at Seeking Alpha - Tue Dec 02, 2:42AM CST
PDI: 29.51 (unch), NFJ: 16.41 (-0.10), PCI: 20.56 (+0.02), IGA: 11.64 (+0.02), DVHL: 24.31 (+0.24), SDRL: 12.32 (-0.70), MORL: 19.93 (+0.09), GGN: 7.59 (+0.12), BQR: 7.57 (+0.01), EOS: 14.19 (+0.11), JRI: 19.24 (+0.12), BIT: 17.66 (-0.01), BOE: 13.57 (+0.08), EDI: 14.88 (+0.18), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), OXLC: 15.22 (-0.12), EDF: 15.46 (+0.03), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), TYG: 44.58 (+0.21)
Tekla Healthcare Opportunities Introduces Fact Card
Business Wire - Tue Nov 18, 10:44AM CST
Tekla Healthcare Opportunities Fund (NYSE: THQ) is pleased to introduce its first fact card. The fact card, which summarizes Fund information which may include quarterly data regarding the Fund including performance, portfolio holdings and sector information, will be available at www.teklacap.com or by request from the Fund's marketing and support services agent, Destra Capital Investments at (877)855-3434. The Fund intends to publish and distribute fact cards with quarterly data within approximately 15 days after each quarter's end. Please visit the Fund's website or call Destra Capital Investments to obtain the Fund's fact cards as published.
HQL: 27.40 (+0.16), THQ: 20.15 (+0.10), HQH: 34.20 (+0.06)
